JO
PGEN icon

John Overdeck’s Precigen PGEN Stock Holding History

John Overdeck’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$781K Buy
136,970
+64,170
+88% +$277K ﹤0.01% 3807
2026
Q1 		$282K Buy
+72,800
New +$299K ﹤0.01% 4114
2024
Q4 		– Sell
-43,159
Closed -$40.9K – 3419
2024
Q3 		$40.9K Sell
43,159
-5,156
-11% -$6.5K ﹤0.01% 2979
2024
Q2 		$76.3K Sell
48,315
-15,937
-25% -$23.1K ﹤0.01% 2851
2024
Q1 		$93.2K Sell
64,252
-29,548
-32% -$42.4K ﹤0.01% 2839
2023
Q4 		$126K Sell
93,800
-10,200
-10% -$12K ﹤0.01% 2918
2023
Q3 		$148K Hold
104,000
– – ﹤0.01% 2697
2023
Q2 		$120K Sell
104,000
-84,500
-45% -$99.8K ﹤0.01% 2731
2023
Q1 		$200K Buy
188,500
+59,718
+46% +$86.1K ﹤0.01% 2557
2022
Q4 		$196K Sell
128,782
-224,951
-64% -$387K ﹤0.01% 2400
2022
Q3 		$750K Sell
353,733
-206,712
-37% -$436K ﹤0.01% 1591
2022
Q2 		$751K Sell
560,445
-618,533
-52% -$918K ﹤0.01% 1662
2022
Q1 		$2.49M Buy
1,178,978
+733,141
+164% +$1.78M 0.01% 1245
2021
Q4 		$1.65M Buy
445,837
+291,917
+190% +$1.26M ﹤0.01% 2098
2021
Q3 		$768K Buy
153,920
+10,505
+7% +$60.5K ﹤0.01% 2866
2021
Q2 		$935K Sell
143,415
-264,870
-65% -$1.85M ﹤0.01% 2528
2021
Q1 		$2.81M Buy
408,285
+345,152
+547% +$2.92M 0.01% 1442
2020
Q4 		$644K Buy
63,133
+21,500
+52% +$139K ﹤0.01% 2326
2020
Q3 		$146K Sell
41,633
-20,154
-33% -$95.7K ﹤0.01% 2890
2020
Q2 		$308K Sell
61,787
-10,571
-15% -$36K ﹤0.01% 2361
2020
Q1 		$246K Sell
72,358
-257,710
-78% -$1.11M ﹤0.01% 2487
2019
Q4 		$1.81M Buy
330,068
+195,030
+144% +$1.1M 0.01% 1669
2019
Q3 		$772K Buy
135,038
+115,789
+602% +$787K ﹤0.01% 2201
2019
Q2 		$147K Buy
+19,249
New +$104K ﹤0.01% 3149
2019
Q1 		– Sell
-173,590
Closed -$1.14M – 3378
2018
Q4 		$1.14M Buy
+173,590
New +$1.95M ﹤0.01% 1572
2018
Q1 		– Sell
-214,291
Closed -$2.47M – 3424
2017
Q4 		$2.47M Buy
+214,291
New +$3.19M 0.01% 1322

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

John Overdeck's PGEN Position: Q2 2026 in Review

John Overdeck increased its Precigen (PGEN) stake by 88% in Q2 2026, buying an estimated $277K and bringing the position to 136,970 shares worth $781K. The position accounts for ﹤0.01% of the portfolio, ranked #3807.

John Overdeck first reported a position in PGEN in Q4 2017 and has held it in 26 quarters since. The position peaked at $2.81M in Q1 2021. 209 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • John Overdeck held 136,970 shares of Precigen worth $781K as of Q2 2026.
  • John Overdeck bought 64,170 Precigen shares in Q2 2026, an estimated $277K.
  • Precigen made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #3807 holding.
  • John Overdeck first reported a position in Precigen in Q4 2017 and has held it in 26 quarters since.
  • John Overdeck's Precigen position peaked at $2.81M in Q1 2021.
  • 209 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.